Graves’ ophthalmopathy (GO) is an autoimmune disease related to Grave’s disease (GD). The therapeutic strategies for GO patients are based on precise assessment of the activity and severity of the disease. However, the current assessment systems require development to accommodate updates in treatment protocols. As an important adjunct examination, magnetic resonance imaging (MRI) can help physicians evaluate GO more accurately. With the continuous updating of MRI technology and the deepening understanding of GO, the assessment of this disease by MRI has gone through a stage from qualitative to precise quantification, making it possible for clinicians to monitor the microstructural changes behind the eyeball and better integrate clinical manifestations with pathology. In this review, we use orbital structures as a classification to combine pathological changes with MRI features. We also review some MRI techniques applied to GO clinical practice, such as disease classification and regions of interest selection.
CITATION STYLE
Song, C., Luo, Y., Yu, G., Chen, H., & Shen, J. (2022, September 29). Current insights of applying MRI in Graves’ ophthalmopathy. Frontiers in Endocrinology. Frontiers Media S.A. https://doi.org/10.3389/fendo.2022.991588
Mendeley helps you to discover research relevant for your work.